Showing results (1-10 of 31) with videos related to
Sort By:
Pageof 4
Digestive Diseases (Basel, Switzerland)|March 6, 2010
Experimental models of stress and pain: do they help to develop new therapies?Sylvie Bradesi, Emeran A MayerExpert Opinion on Pharmacotherapy|November 5, 2003
Alosetron and irritable bowel syndromeEmeran A Mayer, Sylvie BradesiCurrent Opinion in Pharmacology|November 17, 2007
Novel therapeutic approaches in IBSSylvie Bradesi, Emeran A MayerExpert Opinion on Emerging Drugs|April 26, 2006
Emerging drugs for irritable bowel syndromeSylvie Bradesi, Kirsten Tillisch, Emeran MayerCurrent Opinion in Pharmacology|September 13, 2008
Visceral analgesics: drugs with a great potential in functional disorders?Sylvie Bradesi, Jeremy Herman, Emeran A MayerCurrent Gastroenterology Reports|July 17, 2003
Current insights into the pathophysiology of irritable bowel syndromeInes Schwetz, Sylvie Bradesi, Emeran A MayerExpert Review of Gastroenterology & Hepatology|February 12, 2011
The role of experimental models in developing new treatments for irritable bowel syndromeDaniel P Holschneider, Sylvie Bradesi, Emeran A MayerNeuroimmunomodulation|October 12, 2012
Chronic stress-induced changes in pro-inflammatory cytokines and spinal glia markers in the rat: a time course studyViktoriya Golovatscka, Helena Ennes, Emeran A Mayer, et al.Pain|December 29, 2004
Acute stress-induced hypersensitivity to colonic distension depends upon increase in paracellular permeability: role of myosin light chain kinaseAfifa Ait-Belgnaoui, Sylvie Bradesi, Jean Fioramonti, et al.Pain|April 3, 2003
Stress-induced visceral hypersensitivity in female rats is estrogen-dependent and involves tachykinin NK1 receptorsSylvie Bradesi, Helene Eutamene, Rafael Garcia-Villar, et al.Pageof 4